Shares of TSE CRH opened at C$4.13 on Wednesday. The company has a quick ratio of 1.89, a current ratio of 1.99 and a debt-to-equity ratio of 52.51. CRH Medical has a 1 year low of C$3.09 and a 1 year high of C$5.91.
In related news, Director Edward Wright sold 15,000 shares of the firm’s stock in a transaction on Monday, December 10th. The shares were sold at an average price of C$4.89, for a total transaction of C$73,350.00. Also, Director Ian A. Webb sold 29,620 shares of the firm’s stock in a transaction on Wednesday, December 12th. The shares were sold at an average price of C$4.62, for a total transaction of C$136,844.40.
CRH Medical Corporation provides various products and services to gastroenterologists for the treatment of gastrointestinal diseases in the United States, Canada, and internationally. It offers CRH O'Regan system, a single use, disposable, and hemorrhoid banding technology for treating various grades of hemorrhoid.
Featured Article: What is Cost of Debt?
Receive News & Ratings for CRH Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CRH Medical and related companies with MarketBeat.com's FREE daily email newsletter.